Erschienen in:
01.06.2010 | Editorial
‘Selling sickness: influence on influence’, what constitutes good prescribing in 2010?
verfasst von:
J. W. Foppe van Mil, Martine E. C. van Eijk
Erschienen in:
International Journal of Clinical Pharmacy
|
Ausgabe 3/2010
Einloggen, um Zugang zu erhalten
Excerpt
When a decision is made to prescribe a drug, we carefully balance its intended and unintended effects. Positive effects include minimizing the patient’s complaints and disease risks like premature death [
1]. Negative effects include the possible side-effects in the short and long term [
2]. Guidelines on disease management are based on research evaluating these aspects. The more severe the disease burden or the risks of a condition, the more risks of drug treatment we accept [
1]. …